Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I find MedCity News a great resource for taking the pulse of the market and sourcing potential investment opportunities.”

Bernie Rudnick, Angel investor and advisor, CapGenic Advisors, LLC


Sign up for our daily newsletter


Ohio State hires cancer researcher from Georgetown University

4:16 pm by | 0 Comments

Dr. Peter Shields

The Ohio State University Comprehensive Cancer Center has hired a new deputy director, a top cancer researcher from Georgetown University. 

Dr. Peter Shields‘s primary research focus has been in identifying biomarkers that can be used to assess breast and lung cancer risks, particularly those related to diet, smoking and lifestyle, according to a statement from the Ohio State University Medical Center. A biomarker is a protein found in the blood that can indicate the presence or severity of a certain disease. 

“The more markers we identify, the more aggressive screening and monitoring we can do for people with those markers, and we can also focus better our behavioral interventions and chemoprevention,” Shields said. 

Advertisement

Shields was recently named the president of the American Society of Preventive Oncology and has published more than 180 studies. 

At OSU, he’ll oversee the cancer center’s research program, which includes more than 270 cancer researchers from 11 of OSU’s 14 colleges. 

In addition to the deputy director role, Shields will also be a professor in OSU’s department of internal medicine. 

At Georgetown, Shields was deputy director of the Lombardi Comprehensive Cancer Center

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Brandon Glenn

By Brandon Glenn MedCity News

Brandon Glenn is the Ohio bureau chief for MedCity News.
More posts by Author

0 comments